Page results
-
This information has been written for patients who are having total body irradiation (TBI) for a haematological cancer.
-
For people with autoimmune conditions, including multiple sclerosis (MS) and scleroderma: Collecting stem cells from your blood
-
The UCLH Department of Rheumatology is a UK centre of excellence for clinical care, training and research.
-
This page has been written for patients who are receiving proton beam therapy (PBT) to the prostate.
-
This information will help you understand your forthcoming treatment and contains answers to many frequently asked questions.
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
The special haematology service provides a comprehensive investigation of haemolytic amaemia, haemoglobinopathies and red cell enzymopathy.
-
This page explains what autologous stem cell transplant is and includes information about our stem cell transplant service and process, the care patients will receive and what to expect after the transplant.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
This page has been written for patients having proton beam therapy (PBT) at University College Hospital (UCH).
File results
-
FOI/2023/0203 - Maintenance contract(s) for flexible endoscope inventory
-
FOI/2023/0210 - Top five drugs that expired by value
-
FOI/2023/0211 - Services available to older residents
-
FOI/2023/0212 - Training provided to clinical staff for use of medical devices
-
FOI/2023/0222 - Contact details for senior screening and immunisations staff
-
FOI/2023/0231 - Patients seen at A&E with symptoms of taking nitrous oxide gas
-
FOI/2023/0237 - Software solution to manage patient e-consent for school vaccinations/ immunisations and waitlist validation
-
FOI/2023/0250 - Early Access to Medicines Scheme (EAMS)
-
FOI/2023/0251 - Vials used for immunoglobulin drugs - January to March 2023
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)